相似文献
1
Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?
EPMA J. 2010 Jun;1(2):237-44. doi: 10.1007/s13167-010-0031-4. Epub 2010 Jun 29.
2
[Aiming for zero blindness].
Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194.
3
What are the biomarkers for glaucoma?
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S155-61. doi: 10.1016/j.survophthal.2007.08.011.
4
[The Keyrole of Multiomics in the Predictive, Preventive and Personalised Medical Approach towards Glaucoma Management].
Klin Monbl Augenheilkd. 2018 Feb;235(2):146-150. doi: 10.1055/s-0044-101164. Epub 2018 Feb 15.
5
MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer's Disease.
Int J Mol Sci. 2023 Oct 5;24(19):14932. doi: 10.3390/ijms241914932.
6
Neurodegeneration: accelerated ageing or inadequate healthcare?
EPMA J. 2010 Jun;1(2):211-5. doi: 10.1007/s13167-010-0030-5. Epub 2010 Jun 29.
7
Biochemical-molecular-genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients.
Front Med (Lausanne). 2023 May 26;10:1157773. doi: 10.3389/fmed.2023.1157773. eCollection 2023.
8
Leptin as a neuroprotective agent in glaucoma.
Med Hypotheses. 2013 Nov;81(5):797-802. doi: 10.1016/j.mehy.2013.08.023. Epub 2013 Aug 29.
9
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2.
Sci Rep. 2022 Jun 10;12(1):9564. doi: 10.1038/s41598-022-13573-8.
10
Solving neurodegeneration: common mechanisms and strategies for new treatments.
Mol Neurodegener. 2022 Mar 21;17(1):23. doi: 10.1186/s13024-022-00524-0.
引用本文的文献
1
Genetic association of lipid traits and lipid-related drug targets with normal tension glaucoma: a Mendelian randomization study for predictive preventive and personalized medicine.
EPMA J. 2024 Jul 13;15(3):511-524. doi: 10.1007/s13167-024-00373-5. eCollection 2024 Sep.
2
The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
EPMA J. 2024 Feb 27;15(1):1-23. doi: 10.1007/s13167-024-00356-6. eCollection 2024 Mar.
3
Machine learning-couched treatment algorithms tailored to individualized profile of patients with primary anterior chamber angle closure predisposed to the glaucomatous optic neuropathy.
EPMA J. 2023 Aug 17;14(3):527-538. doi: 10.1007/s13167-023-00337-1. eCollection 2023 Sep.
4
The correlation between primary open-angle glaucoma (POAG) and gut microbiota: a pilot study towards predictive, preventive, and personalized medicine.
EPMA J. 2023 Aug 11;14(3):539-552. doi: 10.1007/s13167-023-00336-2. eCollection 2023 Sep.
5
New insight of metabolomics in ocular diseases in the context of 3P medicine.
EPMA J. 2023 Feb 17;14(1):53-71. doi: 10.1007/s13167-023-00313-9. eCollection 2023 Mar.
6
Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure glaucoma: potential biomarkers for 3P medical approaches.
EPMA J. 2021 Nov 2;12(4):659-675. doi: 10.1007/s13167-021-00260-3. eCollection 2021 Dec.
7
Candidate Glaucoma Biomarkers: From Proteins to Metabolites, and the Pitfalls to Clinical Applications.
Biology (Basel). 2021 Aug 10;10(8):763. doi: 10.3390/biology10080763.
8
Citrate usage in the leading causes of blindness: new possibilities for the old metabolite.
Metabolomics. 2018;14(6):82. doi: 10.1007/s11306-018-1377-1. Epub 2018 Jun 5.
9
Plasma citrate concentration: a possible biomarker for glaucoma in children.
BMJ Paediatr Open. 2017 Jul 3;1(1):e000023. doi: 10.1136/bmjpo-2017-000023. eCollection 2017.
10
Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine.
EPMA J. 2018 Feb 22;9(1):15-20. doi: 10.1007/s13167-018-0127-9. eCollection 2018 Mar.
本文引用的文献
1
Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs.
EPMA J. 2010 Jun;1(2):263-72. doi: 10.1007/s13167-010-0032-3. Epub 2010 Jun 29.
2
Disease proteomics reveals altered basic gene expression regulation in leukocytes of Normal-Tension and Primary Open-Angle glaucoma patients.
Proteomics Clin Appl. 2007 Oct;1(10):1316-23. doi: 10.1002/prca.200700150. Epub 2007 Sep 11.
3
4
What is the present pathogenetic concept of glaucomatous optic neuropathy?
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S162-73. doi: 10.1016/j.survophthal.2007.08.012.
5
What are the biomarkers for glaucoma?
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S155-61. doi: 10.1016/j.survophthal.2007.08.011.
6
Does the blood-brain barrier play a role in Glaucoma?
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S115-21. doi: 10.1016/j.survophthal.2007.08.005.
7
Renal sodium handling in patients with normal pressure glaucoma.
Clin Sci (Lond). 2007 Jun;112(6):337-44. doi: 10.1042/CS20060082.
8
Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?
Br J Ophthalmol. 2006 Nov;90(11):1366-9. doi: 10.1136/bjo.2006.094912. Epub 2006 Jun 29.
9
Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma.
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1491-9. doi: 10.1167/iovs.05-0736.
10
Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):968-76. doi: 10.1167/iovs.05-0685.
Zotero 插件
